Bellerophon Therapeutics Inc (NASDAQ:BLPH)

11.85
Delayed Data
As of Aug 14
 -0.40 / -3.27%
Today’s Change
3.19
Today|||52-Week Range
26.00
+125.91%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$116.1M

Company Description

Bellerophon Therapeutics, Inc. focuses on developing products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline include PH-ILD, PH-COPD, and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.

Contact Information

Bellerophon Therapeutics, Inc.
184 Liberty Corner Road
Warren New Jersey 07059
P:(908) 574-4770
Investor Relations:

Employees

Shareholders

Mutual fund holders5.33%
Other institutional14.60%
Individual stakeholders0.64%

Top Executives

Fabian TenenbaumChief Executive Officer & Director
Parag Suresh ShahVice President-Business Operations
Assaf KornerChief Financial Officer & Secretary
Amy EdmondsVP-Clinical Operations & Administration
Wassim FaresChief Medical Officer